ANEMIA
PADMAVATHI.S
1STYEAR POST GRADUATE
DEPT OF ORAL MEDICINEAND RADIOLOGY
CONTENTS
 PERNICIOUSANEMIA
 APLASTICANEMIA
 SIDEROBLASTICANEMIA
 MEGALOBLASTICANEMIA
PERNICIOUS
ANEMIA
DEFINATION:
Pernicious anaemia is defined as a type of vitamin B12 deficiency
that results from impaired uptake of vitamin B-12 due to the lack of
a substance known as intrinsic factor (IF) produced by the stomach
lining.
Recommended dietary allowance of 2 µg/d.
AETIOLOGY:
 Lack ofVitamin B12 in diet
 Lack of intrinsic factor
 Small intestine conditions
PATHOGENESIS:
CLINICAL MANIFESTATIONS:
SIGNS AND SYMPTOMS:
Persons over the age of 30 years of both the gender.
ANEMIC SYMPTOMS NEUROLOGICAL
SYMPTOMS
GIT SYMPTOMS
PALLOR TINGLING OF EXTREMITIES NAUSEA
WEAKNESS BURNING OF EXTREMITIES VOMITTING
FATIGUE PARAESTHESIA
NUMBNESS
DIARRHOEA
SHORTNESSOF BREATH
HEADACHE
ORAL MANIFESTATIONS:
 GLOSSITIS– BEEFY REDTONGUE
 TASTE ALTERATIONS
 BURNING MOUTH
 ASSOCIATEDWITH HUNTER’S/MOELLER’SGLOSSITIS
 DIAGNOSIS
Decreased serum vitamin b12 with normal folate levels.
Serum antibodies against intrinsic factors specific for diagnosis.
Blood smear has macrocytic and hyperchromic
Lower haemoglobin level due to decreased erythrocytes.
Hyperpigmented granulocytes – multiple lobules of nucleus
Bone marrow aspiration – megaloblasts
Gastric analysis - achlorhydria
Patients with low serum Cbl levels (<74 pmol/L [100 pg/mL]) usually have Cbl deficiency
TREATMENT:
 Oral replacement of B12 1000-2000Qg/day has been effective
 Intra-muscular injection of B12 of 1000Qg every day for 1st week
and every week of the subsequent month and every month for the
subsequent year.
 This is a lifelong treatment plan.
COMPLICATIONS
 In severe cases, patients may have decreased numbers of leukocytes (white blood cells) and
platelets in blood.This can result in infections, easy bruising, and bleeding
 Those who are severely deficient in vitamin B12, can also develop bilateral peripheral neuropathy or
spinal cord degeneration, causing numbness and muscle weakness in the arms and legs, and
difficulty walking
 Psychiatric symptoms and dementia may be present with severe vitamin B12 deficiency
 Individuals with pernicious anemia (due to B12 deficiency) are at risk of gastric cancer
 Infants deficient in vitamin B12 may have poor brain development
 Congestive heart failure
APLASTIC
ANEMIA
DEFINATION:
Reduction in the amount of haemotopoietic tissue causing inability
to produce mature cells for discharge into the bloodstream is known
as aplastic anemia.
Men and women are affected with equal frequency.
Age distribution is biphasic, with the major peak in the teens and
twenties and a second rise in older adults.
AETIOLOGY:
INHERITED
 Fanconi's anemia
 Dyskeratosiscongenita
 Shwachman-Diamond syndrome
 Reticular dysgenesis
 Amegakaryocytic thrombocytopenia
 Familial aplasticanemias
 Preleukemia (monosomy 7, etc.)
 Nonhematologic syndrome (Down, Dubowitz, Seckel)
ACQUIRED
 Radiation
 Drugs and chemicals – Benzene,
 Viruses (non-A, non-B, non-C Hepatitis, EBV, Parvovirus B19, HIV-1)
 Immune diseases (Eosinophilic fasciitis,Thymoma, Hyperimmunoglobulinemia,Graft-versus-host
disease)
 Paroxysmal nocturnal hemoglobinuria,
 Pregnancy
 Idiopathic
PATHOPHYSIOLOGY:
 Bone marrow failure results from severe damage to the hematopoietic cell compartment.
 There is replacement of the bone marrow by fat.
 An intrinsic stem cell defect exists for the constitutional aplastic anemias.
 Extrinsic damage to the marrow follows massive physical or chemical insults such as high doses of
radiation and toxic chemicals.
 Immune mediators like HelperT cells,TNF, IFN-ϒ may be involved in the pathogenesis.
CLINICAL PRESENTATION:
 Can appear seeming abruptly or have a more insidious onset.
 Bleeding is the most common early symptom.
 Easy bruising, oozing from the gums, epistaxis, heavy menstrual flow, and sometimes petechie
(massive hemorrhage is unusual)
 Symptoms of anemia are also frequent, including lassitude, weakness, shortness of breath, and a
pounding sensation in the ears.
 Infection (due to leukopenia) is an unusual first symptom in aplastic anemia.
 Pallor
 Petechiae and ecchymoses.
 ORAL MANIFESTATIONS
Oral manifestations are common in patients with aplastic anemia and are directly associated with
pancytopenia.These manifestations include
 petechial hemorrhages,
 gingival swelling and spontaneous bleeding,
 ulceration,
 pallor
 severe periodontal disease.
DIAGNOSIS:
BLOOD:-
Smear shows large erythrocytes and a paucity of platelets and
granulocytes.
Reticulocytes are absent or few.
BONE MARROW:-
Fatty biopsy specimen may be grossly pale
Dilute smear
“Dry tap" instead suggests fibrosis or myelophthisis
TREATMENT:
 Hematopoietic growth factors
 Immunosuppression
 Stem cell transplantation
 Supplementation of blood products and supportive care
SIDEROBLAST
ICANEMIA
DEFINATION:
The sideroblastic anemias are a group of blood disorders in which
the body has enough iron but is unable to use it to make
hemoglobin, which carries oxygen in the blood.As a result, iron
accumulates in the mitochondria of red blood cells, giving a ringed
appearance to the nucleus (ringed sideroblast).
AETIOLOGY:
Toxins: lead, copper, or zinc poisoning
Drug- induced: ethanol, isoniazid, chloramphenicol, cycloserine,
Linezolid, oral contraceptives
Nutritional: pyridoxine (Vitamin B6) or copper deficiency
Diseases: Rheumatoid arthritis or multiple myeloma
Genetic: ALA synthase deficiency (X-linked, associated with ALAS2
CLASSIFICATION:
TheWHO InternationalWorking Group on Morphology of MDS
(IWGM-MDS) defined three types of sideroblasts:
 Type 1 sideroblasts: fewer than 5 siderotic granules in the
cytoplasm
 Type 2 sideroblasts: 5 or more siderotic granules, but not in a
perinuclear distribution
 Type 3 or ring sideroblasts: 5 or more granules in a perinuclear
position, surrounding the nucleus or encompassing at least one
third of the nuclear circumference.
Type 1 and type 2 are found in non-sideroblastic anemias.Type 3 is
found only in sideroblastic anemia.
DIAGNOSIS:
 Serum Iron: high
 increased ferritin levels
 decreased total iron binding capacity
 high transferrin saturation
 Haemtocrit of about 20-30%
 The mean corpuscular volume or MCV is usually normal or low for
congenital causes of sideroblastic anemia but normal or high for
acquired forms.
 With lead poisoning, see coarse basophilic stippling of red blood cells
on peripheral blood smear
 Specific test: Prussian blue stain of RBC in marrow shows ringed
sideroblasts. Prussian blue staining involves a non-enzymatic reaction
of ferrous iron with ferrocyanide forming ferric-ferrocyanide, which is
blue in color. A counterstain may be used to provide better
visualization.
TREATMENT:
1.Anemia is so severe that support with transfusion is required.
2. Patients usually do not respond to erythropoietin therapy.
3. Improved heme level by moderate to high doses ofVitamin
4. Severe cases of SBA, bone marrow transplant with limited information about the success rate.
5. In the case of isoniazid-induced sideroblastic anemia, the addition of B6 is sufficient to correct
the anemia.
6. Desferrioxamine is used to treat iron overload from transfusions.
7. Bone MarrowTransplant (BMT) is the last possible treatment
MEGALOBLAS
TICANEMIA
Megaloblastic anaemia is a red blood cell disorder due to the
inhibition of DNA synthesis during erythropioesis. Mitotically, the
inhibition of the DNA synthesis impaires the progression of the cell
cycle development from G2 to (M) stage.
DAILY REQUIREMENTS:
Adult : 3 μg
Infants & children: 1.0- 1.5 μg
Pregnancy & lactation: 6 μg
ETIOLOGY
 FOLATE DEFICIENCY
Dietary
Malabsorption
 B12 DEFICIENCY
Dietary
Fish tapeworm
 PERNICIOUSANEMIA
Lack of gastric intrinsic factors(IF) for absorption
PATHOGENESIS:
 Lack of B12 allows folic acid to be trapped as non functional methyl tetrahydrofolate(folate trap).
 So deficiency of functional FH4 causes impairment of formation of deoxy thymidine
monophosphate(dTMP) which is needed for DNA synthesis.
 As a result large proerythroblast fails to divide rapidly to make mature RBC rather immature
precursors of erythocyte(blast cell) appear to cause megaloblastic anaemia.
SIGNS AND SYMPTOMS
 Shortness of breath
 Muscle weakness
 Abnormal paleness of the skin
 Glossitis (swollen tongue)
 Loss of appetite/weight loss
 Diarrhea
 Nausea
 Fast heartbeat
 Smooth or tender tongue
 Tingling in hands and feet
 Numbness in extremities
ORAL MANIFSTATIONS
 Glossitis
 Angular cheilitis
 Recurrent oral ulcer
 Oral candidiasis
 Diffuse erythematous mucositis
DIAGNOSIS:
 CBC
Low hemoglobin level and elevated MCV.
 PB morphology
Macrocytosis, macro-ovalocytes and hyper segmented neutrophils.
 Chemical testing
Serum folic acid Low (RC FA)
 BM
Hyper cellular BM
Megaloblastic picture (large cells with increased RNA per DNA unit).
 SchillingTest
The schilling test is used to determine whether there is faulty absorption of vitamin B12.
 TREATMENT:
Hydroxycobalamin 5-10 ug/day IM for two weeks.
A brisk reticulocyte response after one week.
Followed by 1000 ug every three months.
Folate deficiency is treated with oral Folic acid 5 mg /day for 15 days then followed by 1mg/day.
Prophylactically in pregnancy, premature babies dialysis, and chronic hemolysis.
Folic acid should not given alone until B12 has been excluded to prevent precipitate neurological
changes.

gen path.pptx

  • 1.
  • 2.
    CONTENTS  PERNICIOUSANEMIA  APLASTICANEMIA SIDEROBLASTICANEMIA  MEGALOBLASTICANEMIA
  • 3.
    PERNICIOUS ANEMIA DEFINATION: Pernicious anaemia isdefined as a type of vitamin B12 deficiency that results from impaired uptake of vitamin B-12 due to the lack of a substance known as intrinsic factor (IF) produced by the stomach lining. Recommended dietary allowance of 2 µg/d.
  • 5.
    AETIOLOGY:  Lack ofVitaminB12 in diet  Lack of intrinsic factor  Small intestine conditions
  • 6.
  • 7.
    SIGNS AND SYMPTOMS: Personsover the age of 30 years of both the gender. ANEMIC SYMPTOMS NEUROLOGICAL SYMPTOMS GIT SYMPTOMS PALLOR TINGLING OF EXTREMITIES NAUSEA WEAKNESS BURNING OF EXTREMITIES VOMITTING FATIGUE PARAESTHESIA NUMBNESS DIARRHOEA SHORTNESSOF BREATH HEADACHE
  • 8.
    ORAL MANIFESTATIONS:  GLOSSITIS–BEEFY REDTONGUE  TASTE ALTERATIONS  BURNING MOUTH  ASSOCIATEDWITH HUNTER’S/MOELLER’SGLOSSITIS
  • 9.
     DIAGNOSIS Decreased serumvitamin b12 with normal folate levels. Serum antibodies against intrinsic factors specific for diagnosis. Blood smear has macrocytic and hyperchromic Lower haemoglobin level due to decreased erythrocytes. Hyperpigmented granulocytes – multiple lobules of nucleus Bone marrow aspiration – megaloblasts Gastric analysis - achlorhydria
  • 11.
    Patients with lowserum Cbl levels (<74 pmol/L [100 pg/mL]) usually have Cbl deficiency
  • 12.
    TREATMENT:  Oral replacementof B12 1000-2000Qg/day has been effective  Intra-muscular injection of B12 of 1000Qg every day for 1st week and every week of the subsequent month and every month for the subsequent year.  This is a lifelong treatment plan.
  • 13.
    COMPLICATIONS  In severecases, patients may have decreased numbers of leukocytes (white blood cells) and platelets in blood.This can result in infections, easy bruising, and bleeding  Those who are severely deficient in vitamin B12, can also develop bilateral peripheral neuropathy or spinal cord degeneration, causing numbness and muscle weakness in the arms and legs, and difficulty walking  Psychiatric symptoms and dementia may be present with severe vitamin B12 deficiency  Individuals with pernicious anemia (due to B12 deficiency) are at risk of gastric cancer  Infants deficient in vitamin B12 may have poor brain development  Congestive heart failure
  • 14.
    APLASTIC ANEMIA DEFINATION: Reduction in theamount of haemotopoietic tissue causing inability to produce mature cells for discharge into the bloodstream is known as aplastic anemia. Men and women are affected with equal frequency. Age distribution is biphasic, with the major peak in the teens and twenties and a second rise in older adults.
  • 16.
    AETIOLOGY: INHERITED  Fanconi's anemia Dyskeratosiscongenita  Shwachman-Diamond syndrome  Reticular dysgenesis  Amegakaryocytic thrombocytopenia  Familial aplasticanemias  Preleukemia (monosomy 7, etc.)  Nonhematologic syndrome (Down, Dubowitz, Seckel)
  • 17.
    ACQUIRED  Radiation  Drugsand chemicals – Benzene,  Viruses (non-A, non-B, non-C Hepatitis, EBV, Parvovirus B19, HIV-1)  Immune diseases (Eosinophilic fasciitis,Thymoma, Hyperimmunoglobulinemia,Graft-versus-host disease)  Paroxysmal nocturnal hemoglobinuria,  Pregnancy  Idiopathic
  • 19.
    PATHOPHYSIOLOGY:  Bone marrowfailure results from severe damage to the hematopoietic cell compartment.  There is replacement of the bone marrow by fat.  An intrinsic stem cell defect exists for the constitutional aplastic anemias.  Extrinsic damage to the marrow follows massive physical or chemical insults such as high doses of radiation and toxic chemicals.  Immune mediators like HelperT cells,TNF, IFN-ϒ may be involved in the pathogenesis.
  • 20.
    CLINICAL PRESENTATION:  Canappear seeming abruptly or have a more insidious onset.  Bleeding is the most common early symptom.  Easy bruising, oozing from the gums, epistaxis, heavy menstrual flow, and sometimes petechie (massive hemorrhage is unusual)  Symptoms of anemia are also frequent, including lassitude, weakness, shortness of breath, and a pounding sensation in the ears.  Infection (due to leukopenia) is an unusual first symptom in aplastic anemia.  Pallor  Petechiae and ecchymoses.
  • 21.
     ORAL MANIFESTATIONS Oralmanifestations are common in patients with aplastic anemia and are directly associated with pancytopenia.These manifestations include  petechial hemorrhages,  gingival swelling and spontaneous bleeding,  ulceration,  pallor  severe periodontal disease.
  • 22.
    DIAGNOSIS: BLOOD:- Smear shows largeerythrocytes and a paucity of platelets and granulocytes. Reticulocytes are absent or few. BONE MARROW:- Fatty biopsy specimen may be grossly pale Dilute smear “Dry tap" instead suggests fibrosis or myelophthisis
  • 24.
    TREATMENT:  Hematopoietic growthfactors  Immunosuppression  Stem cell transplantation  Supplementation of blood products and supportive care
  • 25.
    SIDEROBLAST ICANEMIA DEFINATION: The sideroblastic anemiasare a group of blood disorders in which the body has enough iron but is unable to use it to make hemoglobin, which carries oxygen in the blood.As a result, iron accumulates in the mitochondria of red blood cells, giving a ringed appearance to the nucleus (ringed sideroblast).
  • 26.
    AETIOLOGY: Toxins: lead, copper,or zinc poisoning Drug- induced: ethanol, isoniazid, chloramphenicol, cycloserine, Linezolid, oral contraceptives Nutritional: pyridoxine (Vitamin B6) or copper deficiency Diseases: Rheumatoid arthritis or multiple myeloma Genetic: ALA synthase deficiency (X-linked, associated with ALAS2
  • 27.
    CLASSIFICATION: TheWHO InternationalWorking Groupon Morphology of MDS (IWGM-MDS) defined three types of sideroblasts:  Type 1 sideroblasts: fewer than 5 siderotic granules in the cytoplasm  Type 2 sideroblasts: 5 or more siderotic granules, but not in a perinuclear distribution  Type 3 or ring sideroblasts: 5 or more granules in a perinuclear position, surrounding the nucleus or encompassing at least one third of the nuclear circumference. Type 1 and type 2 are found in non-sideroblastic anemias.Type 3 is found only in sideroblastic anemia.
  • 28.
    DIAGNOSIS:  Serum Iron:high  increased ferritin levels  decreased total iron binding capacity  high transferrin saturation  Haemtocrit of about 20-30%  The mean corpuscular volume or MCV is usually normal or low for congenital causes of sideroblastic anemia but normal or high for acquired forms.  With lead poisoning, see coarse basophilic stippling of red blood cells on peripheral blood smear  Specific test: Prussian blue stain of RBC in marrow shows ringed sideroblasts. Prussian blue staining involves a non-enzymatic reaction of ferrous iron with ferrocyanide forming ferric-ferrocyanide, which is blue in color. A counterstain may be used to provide better visualization.
  • 29.
    TREATMENT: 1.Anemia is sosevere that support with transfusion is required. 2. Patients usually do not respond to erythropoietin therapy. 3. Improved heme level by moderate to high doses ofVitamin 4. Severe cases of SBA, bone marrow transplant with limited information about the success rate. 5. In the case of isoniazid-induced sideroblastic anemia, the addition of B6 is sufficient to correct the anemia. 6. Desferrioxamine is used to treat iron overload from transfusions. 7. Bone MarrowTransplant (BMT) is the last possible treatment
  • 30.
    MEGALOBLAS TICANEMIA Megaloblastic anaemia isa red blood cell disorder due to the inhibition of DNA synthesis during erythropioesis. Mitotically, the inhibition of the DNA synthesis impaires the progression of the cell cycle development from G2 to (M) stage. DAILY REQUIREMENTS: Adult : 3 μg Infants & children: 1.0- 1.5 μg Pregnancy & lactation: 6 μg
  • 31.
    ETIOLOGY  FOLATE DEFICIENCY Dietary Malabsorption B12 DEFICIENCY Dietary Fish tapeworm  PERNICIOUSANEMIA Lack of gastric intrinsic factors(IF) for absorption
  • 32.
    PATHOGENESIS:  Lack ofB12 allows folic acid to be trapped as non functional methyl tetrahydrofolate(folate trap).  So deficiency of functional FH4 causes impairment of formation of deoxy thymidine monophosphate(dTMP) which is needed for DNA synthesis.  As a result large proerythroblast fails to divide rapidly to make mature RBC rather immature precursors of erythocyte(blast cell) appear to cause megaloblastic anaemia.
  • 33.
    SIGNS AND SYMPTOMS Shortness of breath  Muscle weakness  Abnormal paleness of the skin  Glossitis (swollen tongue)  Loss of appetite/weight loss  Diarrhea  Nausea  Fast heartbeat  Smooth or tender tongue  Tingling in hands and feet  Numbness in extremities ORAL MANIFSTATIONS  Glossitis  Angular cheilitis  Recurrent oral ulcer  Oral candidiasis  Diffuse erythematous mucositis
  • 34.
    DIAGNOSIS:  CBC Low hemoglobinlevel and elevated MCV.  PB morphology Macrocytosis, macro-ovalocytes and hyper segmented neutrophils.  Chemical testing Serum folic acid Low (RC FA)  BM Hyper cellular BM Megaloblastic picture (large cells with increased RNA per DNA unit).  SchillingTest The schilling test is used to determine whether there is faulty absorption of vitamin B12.
  • 35.
     TREATMENT: Hydroxycobalamin 5-10ug/day IM for two weeks. A brisk reticulocyte response after one week. Followed by 1000 ug every three months. Folate deficiency is treated with oral Folic acid 5 mg /day for 15 days then followed by 1mg/day. Prophylactically in pregnancy, premature babies dialysis, and chronic hemolysis. Folic acid should not given alone until B12 has been excluded to prevent precipitate neurological changes.